GAFA
ZBH icon

Garton & Associates Financial Advisors’s Zimmer Biomet ZBH Stock Holding History

Garton & Associates Financial Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-56
Closed -$5.01K – 719
2025
Q4 		$5.01K Buy
+56
New +$5.31K ﹤0.01% 996

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Garton & Associates Financial Advisors's ZBH Position: Q1 2026 in Review

Garton & Associates Financial Advisors sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 56 shares — an estimated $5.01K sold.

Garton & Associates Financial Advisors first reported a position in ZBH in Q4 2025 and held it in 1 quarter. The position peaked at $5.01K in Q4 2025. 916 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Garton & Associates Financial Advisors reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Garton & Associates Financial Advisors sold 56 Zimmer Biomet shares in Q1 2026, an estimated $5.01K.
  • Garton & Associates Financial Advisors first reported a position in Zimmer Biomet in Q4 2025 and held it in 1 quarter.
  • Garton & Associates Financial Advisors's Zimmer Biomet position peaked at $5.01K in Q4 2025.
  • 916 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Garton & Associates Financial Advisors's 13F filing for Q1 2026, filed 11 May 2026.